Access to healthcare: a daily emergency

Every day, millions of people are unable to access medical innovations that could protect their lives and improve their health. Despite decades of progress, many healthcare products remain unavailable or unaffordable for people in low- and middle-income countries.

We live in a golden age of medical science. But more than two billion people can’t access medicines, vaccines and new technologies, causing preventable illness, disease and death.

The world has become numb to a daily emergency

Every day, millions of people face illness and death because they cannot access the medical innovations that would protect, diagnose, treat or cure them.

This is a daily health emergency. But it is one that has been going on for decades. The problem is so large and persistent that the world has become numb to it.

Huge inequalities exist in access to healthcare. People living in high-income countries usually have access to the medicines they need when they need them. Those same medicines might not reach people in low- and middle-income countries for years or even decades. And if they are available, they may be in limited supply or at a price that is unaffordable.

Until we bridge the gap between makers and buyers, lifechanging health products will remain out of reach for billions of people.

What it means for healthcare providers

Being able to prescribe the right medicine at the right time is essential for healthcare providers.

If products are in short supply, doctors often spend time looking for alternatives or, in some cases, tailoring completely different treatment plans. This takes time and reduces the number of patients a doctor can see in a day.

Lack of availability also undermines doctor-patient relationships. These relationships are vital for compliance with treatment plans as the patient must have confidence in the doctor and that the plan will work.

When doctors are unable to prescribe the medicines a patient needs, they are more likely to become discouraged and potentially seek other, less effective, options.

An infographic showing 2 billion people cannot access medicines
An infographic showing 2 billion people cannot access medicines

Why products aren’t available

Every day, new medical innovations are being developed. But too often they do not reach the people who would most benefit from them. For people to be able to access health products, they must be available in their country, there must be enough supply, and they must be able to afford them.

Manufacturers often decide not to make products available in markets they consider risky because of inefficiencies or instability. If a product is not registered in a country then it cannot be prescribed or sold there legally.If a manufacturer enters a market it considers risky, it will often allocate smaller volumes, especially when there is no robust visibility on current and future demand.

Finally, even when products are available, they may be priced too high, making them unaffordable for patients, procurers, or governments. The human cost of inefficient markets is people missing out on healthcare products that can protect, save, and improve their lives.

A nurse takes the blood pressure of a pregnant woman. The words 'Access Matters' overlay the image.

Subscribe to our newsletter

Receive regular updates about how our innovative finance work is making healthcare products more affordable and accessible.